Holen Sie sich die Stockscreener-App
444.18
0.38%
-1.70
Handel nachbörslich:
446.03
1.85
+0.42%
Schlusskurs vom Vortag:
$445.88
Offen:
$441.425
24-Stunden-Volumen:
1.81M
Relative Volume:
0.65
Marktkapitalisierung:
$156.92B
Einnahmen:
$11.03B
Nettoeinkommen (Verlust:
$3.16B
KGV:
50.91
EPS:
8.7251
Netto-Cashflow:
$3.22B
1W Leistung:
+3.75%
1M Leistung:
+7.09%
6M Leistung:
-4.81%
1J Leistung:
-18.56%
1-Tages-Spanne:
$437.51
$449.97
1-Wochen-Bereich:
$437.51
$458.88
52-Wochen-Spanne:
$328.57
$603.88
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, RMD, ALC, WST
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
444.18 | 156.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
195.16 | 53.16B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
250.17 | 35.18B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
69.83 | 33.76B | 10.63B | 819.00M | 1.59B | 1.6577 |
WST
West Pharmaceutical Services Inc
|
403.64 | 28.41B | 3.22B | 542.70M | 458.00M | 7.4805 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-21 | Hochstufung | Erste Group | Hold → Buy |
| 2026-10-07 | Eingeleitet | Barclays | Overweight |
| 2026-08-12 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2026-07-30 | Herabstufung | HSBC Securities | Buy → Hold |
| 2026-07-28 | Eingeleitet | UBS | Buy |
| 2026-07-09 | Eingeleitet | BMO Capital Markets | Outperform |
| 2026-03-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-23 | Herabstufung | Erste Group | Buy → Hold |
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Why Is Intuitive Surgical (NASDAQ:ISRG) Back in Focus After Its Quarter? - Kalkine Media
Intuitive Surgical Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views? - Yahoo Finance
Intuitive Surgical (ISRG) Insider Sale: SVP Chief Human Resource - GuruFocus
Intuitive Surgical Insider Sold Shares Worth $1,834,124, According to a Recent SEC Filing - Moomoo
Form 4 Intuitive Surgical Inc: Craig H. Barratt (Director) For: 23 October By Investing.com - Investing.com India
Form 4 Intuitive Surgical Inc: Patricia L. Wadors (SVP Chief Human Resources Offi) For: 23 October - Investing.com Nigeria
Form 4 Intuitive Surgical Inc: Gary S. Guthart (Director) For: 23 October - Investing.com Nigeria
Intuitive Surgical director Gary Guthart sells $9.08M in stock - Investing.com
Intuitive Surgical Insider Sold Shares Worth $9,075,137, According to a Recent SEC Filing - www.marketscreener.com
SEC Form 4 filed by Intuitive Surgical Inc. - Quantisnow
After selling 20,095 shares, Intuitive Surgical (ISRG) director Gary S. Guthart's trust holds 1,204,530. - Stock Titan
Intuitive Surgical (ISRG) is an Incredible Growth Stock: 3 Reasons Why - Zacks Investment Research
Intuitive Surgical (ISRG) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Earnings Estimates Moving Higher for Intuitive Surgical (ISRG): Time to Buy? - Zacks Investment Research
Earnings Estimates Moving Higher for Intuitive Surgical (ISRG): Time to Buy? - Yahoo Finance
2 Beaten-Down Healthcare Stocks to Buy and Hold for the Next Decade - The Motley Fool
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It - Zacks Investment Research
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Stock Forecasts - Yahoo Finance
Intuitive Surgical, Inc. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:ISRG) 2026-10-23 - Seeking Alpha
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI - Zacks Investment Research
Breakfast News: Week in Review - The Motley Fool
New Strong Buy Stocks for October 23rd - Zacks Investment Research
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
Revvity Launches Signals LabGistics to Coordinate Scientific Workflows - Zacks Investment Research
How Has Intuitive Surgical’s Story Changed? - Trefis
Intuitive Surgical Is Maintained at Overweight by JP Morgan - Moomoo
Intuitive Surgical Strikes $450M Deal In Robot Antitrust Suit - Law360
Abbott: 3 Key Takeaways for Long-Term Investors - The Motley Fool
Intuitive Surgical stock drops after Q3 beat (ISRG:NASDAQ) - Seeking Alpha
Intuitive Surgical Q3: The Best Way To Grow May Be To Charge Less (NASDAQ:ISRG) - Seeking Alpha
ISRG Q3 Earnings Call Highlights Pricing and Growth Strategy - Zacks Investment Research
Intuitive Surgical's Q3 Earnings Beat Estimates on Strong System Sales - Zacks Investment Research
Intuitive Surgical's Q3 Earnings Beat Estimates on Strong System Sales - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Crossed Above the 200-Day Moving Average: What That Means for Investors - Yahoo Finance
Intuitive Surgical, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Breakfast News: A $5.7 Billion Flex or Genius? - The Motley Fool
Intuitive Surgical Stock Slides Despite Earnings Beat as Company Discloses Settlement - Barron's
What Intuitive Surgical (ISRG) Said on Its Q3 Earnings Call - Yahoo Finance
Intuitive Surgical (ISRG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Zacks Investment Research
Intuitive Surgical (ISRG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Intuitive Surgical (ISRG) Settles da Vinci Robot Antitrust Case with $450M Charge - GuruFocus
Intuitive Cuts Target as Surgical Robot Procedure Demand Weakens - Bloomberg.com
Intuitive Surgical Tops Q3 Estimates, Shares Tumble - Benzinga
Intuitive Surgical, Inc. (ISRG) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
Intuitive Surgical slides 13% as earnings hit by pre-tax charge - Investing.com
Intuitive Surgical (NASDAQ:ISRG) Reports Upbeat Q3 2026 But Stock Drops 12.7% - Yahoo Finance
Intuitive Announces Third Quarter Earnings - Yahoo Finance
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Intuitive Surgical Inc-Aktie (ISRG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Oct 28 '26 |
Sale |
441.60 |
61 |
26,938 |
581 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Oct 27 '26 |
Sale |
451.63 |
61 |
27,549 |
642 |
| GUTHART FAMILY TRUST | Director |
Oct 23 '26 |
Proposed Sale |
443.85 |
27,139 |
12,045,645 |
0 |
| PATRICIA WADORS | Officer |
Oct 23 '26 |
Proposed Sale |
443.85 |
1,078 |
478,470 |
0 |
| BARRATT CRAIG H | Director |
Oct 23 '26 |
Sale |
443.80 |
1,150 |
510,370 |
0 |
| Widman Fredrik | VP Corporate Controller |
Oct 23 '26 |
Option Exercise |
229.14 |
4,047 |
927,345 |
5,073 |
| BARRATT CRAIG H | Director |
Oct 23 '26 |
Option Exercise |
90.49 |
1,150 |
104,069 |
1,150 |
| WADORS PATRICIA L | SVP Chief Human Resources Offi |
Oct 23 '26 |
Sale |
443.80 |
1,078 |
478,416 |
0 |
| GUTHART GARY S | Director |
Oct 23 '26 |
Sale |
451.61 |
20,095 |
9,075,137 |
1,204,530 |
| FREDRIK WIDMAN | Officer |
Oct 23 '26 |
Proposed Sale |
443.85 |
5,136 |
2,279,614 |
0 |
0.07%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):